A groundbreaking study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…
Read More
Scientists Identify Karyoptosis as a Key Mechanism of Neurodegeneration in Alzheimer’s Disease and Frontotemporal Dementia
In a landmark study that could redefine the scientific understanding of neurodegenerative progression, researchers have identified a previously unknown biological…
Read More
Study Reveals Artery Widening Not Fatty Plaque as Primary Driver of Lacunar Stroke and Small Vessel Disease
The medical community is facing a significant paradigm shift in its understanding of cerebrovascular health as new research challenges long-held…
Read More
Pioneering Immune-Based Therapies: How NK Cell-Derived Extracellular Vesicles Offer New Hope for Traumatic Brain Injury and Alzheimer’s Disease
Traumatic brain injury (TBI) stands as a formidable global health crisis, impacting an estimated 69 million individuals each year with…
Read More
Ipsen Acquires Rare Disease Specialist Memo Therapeutics for up to €700 Million, Bolstering Pipeline with Promising BK Polyomavirus Asset
Paris, France – In a significant strategic move to expand its rare disease portfolio, global biopharmaceutical company Ipsen announced today…
Read More
Sanofi’s Nexviazyme Demonstrates Promising Results in Infants with Infantile-Onset Pompe Disease, Paving Way for Potential Label Expansion
Sanofi’s groundbreaking treatment for Pompe disease, Nexviazyme (avalglucosidase alfa), has achieved a significant milestone with the successful completion of the…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on the shelves of pharmaceutical companies, dormant and…
Read More
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in Sperm
The biological clock has long been a central theme in discussions regarding maternal health and fertility, but a landmark pair…
Read More
Arc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s Disease
The progression of Alzheimer’s disease has long been understood as a relentless march of cellular destruction, fueled by the accumulation…
Read More
High-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration
The multi-billion-dollar global industry built around omega-3 fatty acid supplements has faced a significant scientific setback following the release of…
Read MoreYOU MAY HAVE MISSED
